fig3
![Efficacy and HCC development after DAA therapy for patients with chronic hepatitis C: a single center retrospective cohort study](https://image.oaes.cc/837b5ef5-25fe-44fb-8b90-e73773c78a94/2255.fig.3.png)
Figure 3. A case of sarcoidosis after DAA treatment. A 46-year-old male. After the end of DAA treatment, renal dysfunction occurred. Renal biopsy revealed renal sarcoidosis. Moreover, chest X-P showed BHL while the ophthalmologic examination showed iritis. The eradication of HCV or the DAA treatment itself might have triggered the onset of sarcoidosis. DAA: direct-acting antiviral; BHL: bilateral hilar lymphadenopathy; HCV: hepatic C virus; SOF: sofosbuvir; LDV: ledipasvir; SVR: sustained virological response